Abivax (ABVX)
107.42
-6.16 (5.42%)
Upcoming Events
Latest Headlines
This biotech stock has 'multiblockbuster IBD opportunity': analyst
September 10, 2026 5:00 PM - StreetInsider
Goldman Sachs Starts Abivax (ABVX) at Buy, 'screens well as a potential M&A target'
September 9, 2026 4:41 PM - StreetInsider
Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC
August 14, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Abivax S.A. Filed by: Invus Global Management, LLC
August 13, 2026 10:55 AM - SEC Filing
Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
July 30, 2026 4:07 PM - StreetInsider
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
July 30, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) PT Raised to $180 at Morgan Stanley
July 24, 2026 9:38 AM - StreetInsider
Abivax names four commercial leaders ahead of planned NDA filing
July 23, 2026 4:06 PM - StreetInsider
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
July 23, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) PT Raised to $175; Piper Sandler: 'We remain buyers here'
July 9, 2026 7:11 AM - StreetInsider
Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I
July 6, 2026 9:36 PM - SEC Filing
Form 6-K Abivax S.A. For: Jul 02
July 2, 2026 4:10 PM - SEC Filing
Form 424B5 Abivax S.A.
July 2, 2026 4:07 PM - SEC Filing
Abivax (ABVX) PT Raised to $155 at Truist Securities
July 2, 2026 7:07 AM - StreetInsider
Abivax jumps as fully exercised option lifts share-sale haul to $920 million
July 2, 2026 6:01 AM - StreetInsider
Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease
July 1, 2026 11:53 AM - StreetInsider
Form FWP Abivax S.A. Filed by: Abivax S.A.
July 1, 2026 9:16 AM - SEC Filing
Abivax prices upsized $800M ADS offering at $125 per share
July 1, 2026 9:07 AM - StreetInsider
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
July 1, 2026 9:06 AM - Globe NewsWire
Abivax announces trading resumption of its ordinary shares on Euronext Paris
July 1, 2026 8:56 AM - Globe NewsWire
Abivax prices upsized $800M ADS offering at $125 per share
July 1, 2026 8:37 AM - StreetInsider
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
July 1, 2026 8:37 AM - Globe NewsWire
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Positive ABTECT Data
July 1, 2026 4:39 AM - StreetInsider
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Positive ABTECT Data
July 1, 2026 4:39 AM - StreetInsider
Form FWP Abivax S.A. Filed by: Abivax S.A.
June 30, 2026 5:29 PM - SEC Filing
Form 424B5 Abivax S.A.
June 30, 2026 5:16 PM - SEC Filing
Form POSASR Abivax S.A.
June 30, 2026 4:20 PM - SEC Filing
Jefferies Upgrades Abivax (ABVX) to Buy
June 30, 2026 4:11 PM - StreetInsider
Increasing unusual put volume: SOLS NTR SHW CIA AVAV ABVX LTPH ARKG TTE OLN SOC CHYM VSH
June 30, 2026 10:48 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Abivax (ABVX), 'ABVX remains our Best Idea'
June 30, 2026 6:58 AM - StreetInsider
Abivax (ABVX) PT Raised to $175 at BTIG
June 30, 2026 5:53 AM - StreetInsider
Form 6-K Abivax S.A. For: Jun 29
June 29, 2026 5:22 PM - SEC Filing
Abivax reports Phase 3 maintenance trial results for obefazimod
June 29, 2026 4:06 PM - StreetInsider
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance
June 29, 2026 4:05 PM - Globe NewsWire
Abivax (ABVX) Halted, News Pending
June 29, 2026 4:02 PM - StreetInsider
Full Article List
